IntroductionDuring traumatic periods and their aftermath, our brains can fall into habitual ways of thinking that may be helpful in the short run but...
The psychedelic drug MDMA edges closer towards FDA approval for the treatment of post-traumatic stress disorder (PTSD) in the U.S., after promising results of...
Depression is a complex mental health condition that affects millions of people worldwide. While various treatments exist, one approach gaining attention is monotherapy. In...
Everyone is raving about hallucinogens as the future of antidepressants.LSD (better known as acid), psilocybin (the active ingredient in magic mushrooms), and the “spirit...
Emotional blunting, also referred to as numbness, is common among people who medicate with antidepressants. When this occurs, one can neither feel happy nor sad. You simply...
Emotional blunting, also referred to as numbness, is common among people who medicate with antidepressants. When this occurs, one can neither feel happy nor...
IntroductionPeople often think they know what causes chronic depression. Surveys indicate that more than 80% of the public blames a “chemical imbalance” in the...
The need for intense clinical research on the medical potentials of ketamine has always existed, however getting approval for such research has always been...
At the American Psychiatric Association (APA) 2022 Annual Meeting that began on May 21 in New Orleans, Louisiana, COMPASS Pathways unveiled the “largest randomized,...
